We report on a patient with chronic phase CML who developed hyperbilirubinemia during nilotinib treatment, showing a pattern of UGT1A1 polymorphisms so far undescribed in this clinical setting.
A novel pattern of uridine diphosphate glucuronosyltranferase polymorphisms associated with hyperbilirubinemia during nilotinib treatment
COIANA, ALESSANDRA;ROSATELLI, MARIA CRISTINA;
2013-01-01
Abstract
We report on a patient with chronic phase CML who developed hyperbilirubinemia during nilotinib treatment, showing a pattern of UGT1A1 polymorphisms so far undescribed in this clinical setting.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Blood Cells Mol Dis 2013.pdf
Solo gestori archivio
Tipologia:
versione editoriale (VoR)
Dimensione
110.87 kB
Formato
Adobe PDF
|
110.87 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
